Carregant...
Severe hypercalcemia and hypernatremia in a patient treated with canagliflozin
Drugs that inhibit the sodium-glucose co-transporter-2 (SGLT2) are an exciting novel, insulin-independent treatment for diabetes that block glucose reabsorption from the proximal tubules of the kidney, leading to increased glucose excretion and lower blood glucose levels. Inhibition of SGLT2 activit...
Guardat en:
| Publicat a: | Endocrinol Diabetes Metab Case Rep |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Bioscientifica Ltd
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4501313/ https://ncbi.nlm.nih.gov/pubmed/26191411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-15-0042 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|